Mylan has paid a high price for Sweden’s Meda, but deal has strategic benefits
February 12, 2016 at 07:44 AM EST
Mylan’s $7.2 billion purchase of Meda has strategic value, even if Mylan’s share price fell sharply after the deal was announced.
